Director sold ~$150K of Krystal Biotech
Scheduled in advanceLoading…
Traded Dec 4, 2025 · Filed Dec 5, 2025
The boss of Krystal Biotech sold $2.32M of Krystal Biotech shares. It was planned long ago, so it says very little.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market sale
Code S — open-market or private sale
~$2,320,471
Shares × reported transaction price
31 days after results of Nov 3, 2025, 39 days before results of Jan 12, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Footnote references a pre-arranged trading plan (Rule 10b5-1)
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +3.8% | −0.4% | +4.2% |
| 30 days | +5.3% | +0.9% | +4.4% |
| 90 days | +10.5% | −0.8% | +11.3% |
| 180 days | +28.9% | +8.1% | +20.8% |
Past results only. Not a forecast.
Director sold ~$150K of Krystal Biotech
Scheduled in advanceDirector sold ~$129K of Krystal Biotech
Scheduled in advanceDirector sold ~$304K of Krystal Biotech
Scheduled in advance